Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Travatan vs Cosopt in Glaucoma or Ocular Hypertension
NCT00471068Phase 4Terminated
- Sponsor
- Alcon Inc.
- Start
- Mar 2007
- Primary completion
- Aug 2008
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of travoprost in open-angle glaucoma (OAG) and ocular hypertension, sponsored by Alcon Inc. Primary endpoint: Intraocular Pressure Mean Change at 6 weeks. Started Mar 2007; status: terminated.
02
Drugs
travoprost
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT00471068.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00471068.